India's Biocon in pact with Mylan for biologic drugs

MUMBAI, June 29 (Reuters) - Indian biotechnology firm Biocon Ltd (BION.BO) said on Monday it has signed a definitive agreement with Mylan Inc (MYL.O) to develop, manufacture and supply generic biologic drugs globally.

As part of the agreement, both companies will share development, capital and other costs to bring the products to market, it said in a statement. (Reporting by Janaki Krishnan; Editing by Muralikumar Anantharaman)